* Health Catalyst Inc HCAT.OQ HCAT.O is expected to show
a
rise in quarterly revenue when it reports results on May 10.
* The South Jordan Utah-based company is expected to report
a
18.2% increase in revenue to $66.024 million from $55.85 million
a year ago, according to the mean estimate from 11 analysts,
based on Refinitiv data.
* Refinitiv's mean analyst estimate for Health Catalyst Inc
is
for a loss of 11 cents per share. For the same quarter last
year, the company reported a loss of 6 cents per share.
* The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 15 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts had risen by
about 0.1%
in the last three months.
* Wall Street's median 12-month price target for Health
Catalyst
Inc is $38, above its last closing price of $14.69.
* Previous quarterly performance (using preferred earnings
measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Dec. 31 2021 -0.16 -0.21 -0.19 Beat 10.2
Sep. 30 2021 -0.21 -0.22 -0.18 Beat 17.2
Jun. 30 2021 -0.14 -0.14 0.00 Beat 100
Mar. 31 2021 -0.13 -0.15 -0.06 Beat 59.2
Dec. -0.17 -0.19 -0.16 Beat 17.1
31 2020
Sep. 30 2020 -0.27 -0.27 -0.21 Beat 21.9
Jun. 30 2020 -0.21 -0.22 -0.15 Beat 32.7
Mar. 31 2020 -0.23 -0.25 -0.16 Beat 36.8
This summary was machine generated May 7 at 01:28 GMT. All
figures in US dollars unless otherwise stated